Vasant Jadhav

Over 20 years of experience in the chemical biology research of nucleic acids spanning academic, biotech and big pharma industry for basic, diagnostic and therapeutic applications. Proven record of delivering insightful breakthroughs as an individual contributor and then growing in the role of team leader overseeing several large multi-disciplinary teams in highly collaborative and timely manner to deliver on the objectives. Optimized fully modified siRNA technology and conceived novel siRNA designs- both key assets of Sirna Therapeutics. In addition, managed collaborations with GSK and Allergan as a scientific lead in the field of respiratory and ocular diseases respectively. Initiated, established and currently overseeing biology efforts of Merck’s industry leading siRNA conjugate delivery platform. Led comprehensive efforts to engage internal and external scientific experts to unearth novel ways of enhancing cytosolic release of siRNA- the biggest barrier to fully realize potential of siRNA.